PART 5

Summary for External Professionals

5.1 — Overview

This case study concerns a young adult with a lifelong neurological visual impairment, documented consistently for over 30 years, including:

  • permanent vertical nystagmus

  • impaired eye‑movement control

  • reduced gaze stability

  • spatial‑awareness deficits

  • functional‑vision limitations

These features have been stable and non‑fluctuating throughout the individual’s life.

5.2 — The Issue

In February 2026, the individual underwent a routine WGOS 1 sight test, which was:

  • clinically inappropriate for a neurological condition

  • conducted using the wrong framework

  • missing essential neurovisual and functional‑vision tests

  • not aligned with the long‑term baseline

  • interpreted using ocular assumptions rather than neurological understanding

The resulting clinical letter contained findings that were:

  • unsupported

  • clinically impossible

  • contradictory to the established record

  • unsafe for other professionals to rely upon

5.3 — Key Failures Identified

The assessment failed to:

  • use the correct clinical framework

  • conduct required neurovisual tests

  • assess functional vision

  • recognise or measure neurological features

  • reference the 30‑year clinical baseline

  • provide clinically justified findings

  • meet safeguarding and governance standards

These failures resulted in a clinical letter that misrepresented a permanent neurological impairment as “intermittent” or “variable”, which is not physiologically possible.

5.4 — Safeguarding Implications

Because the 2026 letter:

  • minimised the impairment

  • obscured functional‑vision risk

  • contradicted the long‑term record

  • lacked clinical justification

it is not safe for use by:

  • support workers

  • social‑care professionals

  • mobility specialists

  • educational or employment services

  • other clinicians

Inaccurate information places the individual at risk in real‑world environments and undermines safeguarding.

5.5 — What Needs to Happen

To restore clinical accuracy and ensure safety:

  1. The February 2026 letter must be corrected to reflect the established neurological baseline.

  2. A new assessment must be conducted using a neurovisual and functional‑vision framework.

  3. Continuity of care must be restored by aligning future records with the long‑term baseline.

  4. A safeguarding review is required to ensure professionals are not relying on unsafe information.

  5. The correct clinical pathway must be implemented, including specialist neurovisual monitoring.

  6. The organisation must reflect on the procedural failures to prevent recurrence.

5.6 — Summary Statement

The February 2026 assessment was not clinically appropriate, not procedurally valid, and not safe to rely upon.

 

A specialist reassessment and correction of the clinical record are required to ensure accurate understanding of the individual’s permanent neurological visual impairment and to maintain safeguarding standards.

 

This summary provides external professionals with a clear understanding of the issues, risks, and required actions. The next section contains supporting evidence and appendices.

 

Next Part 6 — Appendices and Evidence

 

 

 

 

 

Design & Copyright Owner Maureen Booth-Martin (MBM) © All rights reserved.

UA-54289644-1